A detailed history of Magnetar Financial LLC transactions in Pfizer Inc stock. As of the latest transaction made, Magnetar Financial LLC holds 25,096 shares of PFE stock, worth $671,067. This represents 0.02% of its overall portfolio holdings.

Number of Shares
25,096
Previous 30,975 18.98%
Holding current value
$671,067
Previous $866,000 16.17%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$27.7 - $31.39 $162,848 - $184,541
-5,879 Reduced 18.98%
25,096 $726,000
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $6.94 Million - $8.6 Million
-151,670 Reduced 83.04%
30,975 $1.6 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $6.27 Million - $9.29 Million
151,670 Added 489.65%
182,645 $10.8 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $1.93 Million - $2.18 Million
-57,598 Reduced 65.03%
30,975 $1.12 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $1.93 Million - $2.45 Million
57,598 Added 185.95%
88,573 $3.26 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $30.1 Million - $36.5 Million
-1,000,000 Reduced 97.0%
30,975 $1.01 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $27 Million - $38.6 Million
1,000,000 Added 3228.41%
1,030,975 $33.7 Million
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $510,951 - $579,864
15,521 Added 100.43%
30,975 $1.21 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $502,100 - $651,077
15,454 New
15,454 $555,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $820,327 - $921,038
-22,183 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $70,575 - $77,538
-1,882 Reduced 7.82%
22,183 $942,000
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $800,401 - $849,253
24,065
24,065 $872,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Magnetar Financial LLC Portfolio

Follow Magnetar Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnetar Financial LLC with notifications on news.